TherapeuticsMD: Q4 Earnings Insights

TherapeuticsMD TXMD reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

TherapeuticsMD missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an estimate of $-0.08.

Revenue was down $3.90 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 4.67% drop in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.10	-0.11	-0.12	-0.10
EPS Actual	-0.11	-0.11	-0.11	-0.15
Revenue Estimate	25.87M	22.11M	19.77M	21.89M
Revenue Actual	25.41M	23.00M	19.87M	22.58M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar